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Autoimmune thyroid diseases (AITD) are a class of chronic, organ-specific 112 autoimmune disorders that affect the thyroid gland with a high genetic heritability (55-113 75%) 1-4 . AITD are diagnosed in approximately 5% of the European population with a 114 gender disparity (i.e., women: 5-15%; men: 1-5%), and represent the most common 115 group of autoimmune diseases [5] [6] [7] . AITD are characterised by a dysregulation of the 116 immune system affecting several biological structures and processes, such as 117 antigen/antibody/effector cell complex formation 8-10 , likely driven by a combination of 118 genetic and environmental factors 11 . 119 Pathologically, AITD are characterized by the production of autoantibodies against the 120 three key thyroid proteins (thyroid peroxidase (TPO), thyroglobulin (Tg), and the 121 thyroid-stimulating hormone (TSH) receptor (TSH-R)), infiltration of the thyroid gland 122 by immune cells (e.g. lymphocytes, NK cells, monocytes, and macrophages), as well 123 as the formation of germinal centers in the thyroid gland 12 . Additionally, several vital 124 pathological players and biomarkers can be found in peripheral blood, such as high 125 levels of thyroid autoantibodies and dysregulated TSH levels 13, 14 . However, some 126 controversy exists surrounding the immune cell composition in peripheral blood 127 associated with AITD. Some studies have failed to observe a significant difference in 128 peripheral blood immune cell composition between AITD patients and healthy 129 individuals 15 , whereas others have reported significant differences in particular cell 130 types or specific marker expression on immune cells. 16 . Immune cells, thyroid 131 autoantibodies, and secreted proteins including cytokines may play critical roles in 132 AITD development 17 and could participate in immune responses including antibody-133 dependent cell-mediated cytotoxicity (ADCC) pathways 18, 19 . 134 ADCC is triggered with the formation of antigen/antibody/Fc receptor complexes 135 bringing the effector cell (macrophages, NK cells) and the target cell (expressing the 136 antigen) in close contact. As the formation and the function of the antigen/antibody 137 complex are modulated by post-translational modifications of proteins 20,21 , we 138 previously studied the glycosylation of total immunoglobulin G (IgG) and peripheral 139 blood mononuclear cells (PBMC) in patients with AITD 4 . We identified a depletion of 140 IgG core fucosylation and antennary α1,2 fucosylation of PBMCs in peripheral blood, 141 associated with TPOAb levels and AITD status 4 . IgG core fucose, which is observed in approximately 95% of IgG in healthy individuals, is considered a "safe switch" by 143 attenuating potentially harmful ADCC activity against self-antigens 22-26 . Therefore, it 144 is possible that the deficiency of IgG core fucose observed in AITD and correlated with 145 elevated TPOAb levels may be associated with TPOAb production in the thyroid gland 146 and could be a player in autoimmune response in AITD by enhancing the cytotoxicity 147 activities of TPOAb against thyrocytes through ADCC. Previous studies showed that 148 afucosylated antibodies have a higher affinity (~100-fold) in binding to the 149 immunoglobulin receptor FcγRIIIa (CD16a), expressed on NK cells, macrophages and 150 γδ T cells, and associated with enhanced ADCC potential in vitro and anti-tumor 151 activity in vivo [22] [23] [24] 26 . Consequently, we hypothesized that particular immune features 152 that accompany Fc-mediated functions of IgG, immune cells and associated 153 inflammation could be detected in PBMC of patients with AITD. 154 Therefore, this in silico study aimed to: 1) investigate the association of different 155 components of antigen/antibody/Fc receptor complexes with AITD, 2) identify 156 interactions between these different immune components, and 3) elucidate genetic 157 and environmental effects on these components within the bloodstream in 622 158 subjects from the TwinsUK cohort, of whom 172 have an AITD diagnosis. More 159 precisely, we examined the association of total serum IgG glycosylation, immune traits, 160 such as immune cell subpopulation frequencies (CSFs; i.e. the relative frequencies of 161 circulating immune cell subsets), immune cell surface protein expression levels 162 (SPELs; i.e. the measurement of the cell-surface expression of critical proteins) and 163 secreted proteins, from the peripheral blood of patients with AITD compared with those 164 in normal volunteer blood. Our study design is summarized in Figure 1 , and the 165 sample sizes of these different studies are described more in detail in Supplement 166 binding to Fc receptors of immune cells 37 . In our previous study 4 , we observed a 204 deficiency of IgG core fucose in the peripheral blood of AITD patients, and it is known 205 that IgG core fucose plays a role in ADCC [22] [23] [24] 26 . Recently, we performed genome-206 wide association studies (GWASs) on 78,000 immune cell traits using a high-207 resolution deep immunophenotyping flow cytometry analysis in 669 twins (497 208 discovery, 172 replication) from the TwinsUK cohort 27,28 and identified genetic variants 209 known to confer autoimmune susceptibility 27,28 . Following quality control of samples 210 and immune cell traits, 383 individuals have been identified to have measurements of 211 23,485 immune cell traits and 17 AITD-IgG N-glycan traits. Consequently, we 212 examined whether levels of the 17 IgG N-glycan traits previously associated with AITD 213 (IGP2, IGP7, IGP8, IGP15, IGP21, IGP33, IGP36, IGP42, IGP45, IGP46, IGP48,  214 IGP56, IGP58, IGP59, IGP60, IGP62 and IGP63) were also associated with the level 215 of specific immune cell trait subpopulations in the TwinsUK cohort (Supplement Table  216 1). We carried out the association analyses taking into account immune trait 217 correlations and the hierarchical nature between different immune cell traits as well as 218 IgG N-glycan trait correlations. We identified 1,357 independent immune cell traits 219 among 23,485 tested immune cell traits, 20 independent IgG N-glycan traits among 220 75 IgG N-glycan traits, and 6 independent AITD-IgG N-glycan traits among 17 AITD-221
IgG N-glycan traits using Li & Ji's method 45 . Association studies of total IgG N-glycan traits with immune cell traits showed that 6 of the 17 significant IgG N-glycan traits 223 (IGP2, IGP42, IGP46, IGP58, IGP59, IGP60) previously associated with TPOAb level  224 and AITD status detected in the TwinsUK cohort, were also associated with 51 225 immune cell traits (Supplement Table 2 , Fig. 2) . Three IgG N-glycan traits (IGP2, 226 IGP42, IGP46) were negatively associated with the level of the activating 227 subpopulation of CD16 + CD56 + CD158b -CD335 + NK cells and positively associated 228 with the level of the CD16 + CD56 + CD335effector NK cell subpopulation and with the 229 activating subpopulation CD16 + CD56 + CD158b + CD314+CD335 -NK cells [39] [40] [41] [42] [43] [44] . In 230 contrast, three other significant IgG N-glycan traits with core fucose (IGP58, IGP59, 231 and IGP60) had the opposite effect associations with the same subpopulations of NK 232 cells ( Fig. 2a ). It is noteworthy that we previously showed that there are negative 233 correlations between the set of IgG N-glycan traits without core fucose (IGP2, IGP42, 234 IGP46) and the set of IgG N-glycan traits describing IgG core fucose (IGP58, IGP59, 235 and IGP60) 4 and these are highlighted in Fig. 2b . Moreover, we observed a strong 236 correlation between these 51 immune cell traits (Fig. 2c) . The presence of correlation 237 patterns between the 17 AITD-IgG N-glycan traits ( Fig. 2b) as well as between the 51 238 immune cell traits ( Fig. 2c) is consistent with our observation of correlations between 239 the 6 AITD-IgG N-glycan traits and the 51 immune cell traits ( Fig. 2a ). Moreover, we 240 extended our analysis to the 58 remaining IgG N-glycan traits also identified in our 241 samples, but not associated with AITD, and we observed no significant association 242 between them and the 23,485 immune cell traits. 243
Consequently, we conclude that a subpopulation of NK cells with a combination of 244 specific immunoreceptors (CD314, CD335, CD2, CD158a, CD158b, R7) is associated 245 with the depletion of IgG core fucose observed in individuals with AITD. We furthermore investigated whether the 23,485 peripheral blood immune cell traits 261 are directly associated with TPOAb levels and AITD status in up to 374 individuals 262 from the TwinsUK cohort (Supplement Table 1 ). We performed association analyses 263 of TPOAb levels and AITD status with all 23,485 immune cell traits, with a particular 264 focus on the 51 immune cell traits identified in the previous analysis (respectively 265 1,357 and 6 independent immune cell traits) ( Fig. 2c and 3a) . No significant 266 associations of immune cell traits with TPOAb level or with AITD status could be 267 detected ( Supplement Table 3 ). These results suggest that even if there are 268 correlations between IgG core fucose levels and immune cell traits in blood, and a 269 correlation between IgG core fucose and AITD, the association between immune cell 270 traits and AITD in blood appears to be mediated by more complex processes 271 (Supplement Fig. 1) . 272
273
The genetic variants, rs1521 and rs3094228, previously associated with AITD alter the associated with activated NK cell states, T cell co-stimulation, and mediating tumor cell lysis 40, 42 . We thus inspected genetic variants associated with AITD, TPOAb levels, 281 and immune cell traits from the previous GWAS 27,28,30 , and compared these with 282 recent large-scale studies on tissue-specific expression quantitative traits (eQTLs), 283 mainly from the GTEx project 32,33 , to determine whether genetic factors could 284 contribute to AITD, related immune features, or their pathways. 285
First, we identified loci and the reported genes with the lead single nucleotide 286 polymorphisms (SNPs) associated with AITD as well as immune cell traits from 287 previous GWASs 27, 28, 30 . No single lead genetic variants identified by our previous 288 immune cell traits GWASs appeared to be also associated with at least one of thyroid 289 phenotypes previously studied and published in the GWAS catalog (e.g., Graves' 290 disease, AITD, TSH level, TPOAb level) 30 . This was also the case when analyses were 291 extended to single nucleotide polymorphisms (SNPs) in linkage disequilibrium (LD; 292 r 2 >0.8). On the other hand, using the adjacent genes identified in previous GWASs 293 and reported in GWAS catalog, we identified 14 genes that have SNPs in or near the 294 gene body, associated with both immune cell traits (30 lead SNPs) and thyroid 295 phenotypes (17 lead SNPs) ( Supplementary Table 4 ). Two genes, HCP5 and MIC-296 A, are associated with TPOAb-positivity and Graves' disease as well as with three 297 immune cell traits (two NK cell types, 16+56/314-158a+ and 16+56/CD2-314+335-298 337-158a+158b+, and one dendritic cell type, 11c+ (nodim)/1c-/16+/32+) ( Fig. 3b) . 299 We then investigated the effect of 47 SNPs associated with immune cell traits and 300 thyroid phenotypes on gene expression in blood and thyroid tissue using eQTLs from 301 the GTEx project and other publications 32, 33, 46 . No genetic variants previously 302 associated with AITD or other thyroid phenotypes appeared to be also associated with 303 the expression of CD335 receptors or its known ligands in blood and thyroid cells. On 304 the other hand, we observed that two SNPs, rs1521 and rs3094228, associated with 305
Graves's diseases and TPOAb-positivity respectively fall in the gene regulatory 306 regions of MIC-A and MIC-B genes, two ligands of CD314 (NKG2D), and also increase 307 their gene expressions in thyroid cells as well as other cell types 32,33,47-49 ( Fig. 3b , 308
Supplement Table 4, Supplement Fig. 2). Consequently, this up-regulation of MIC-309
A and MIC-B gene expressions in thyrocytes could activate the cytotoxicity of NK cells 310 and the cytokine production against thyrocytes when there is binding between NK cells 311 and thyrocytes. Furthermore, rs1521 also reduce the expression of the HLA-C gene, ligand of CD158b, in the thyroid cells, as well as whole blood and other cell types 32,33,46 313 ( Fig. 3b , Supplement Table 4 , Supplement Fig. 2) . This result suggests a potential 314 mechanism where down-regulation of HLA-C gene expression in thyrocytes caused 315 by genetic variants could not inhibit the activation of cytotoxicity of NK cells and 316 cytokine production when there is binding between NK cells and thyrocytes. Two of 317 three SNPs, rs2596460 and rs252369, associated with the level of the subpopulation 318 of NK featuring 16+56/CD2-314+335-337-158a+158b+, fell in the same locus (LD r 2 > 319 0.8) as the AITD-SNP, rs1521, and decrease the expression of HLA-C gene in the 320 whole blood. 321
Overall, two SNPs, rs1521 and rs3094228, associated with respectively Graves' 322 disease and TPOAb-positivity, appear to alter the expression of ligands of two 323 immunoreceptors of NK cells, CD314 and CD158b in thyrocytes, that could increase 324 the activation of cytotoxicity of NK cells after binding with target cells (Supplement 325 In addition to the production of thyroid autoantibodies and reduced levels of IgG core 340 fucose with a subpopulation of NK cells in AITD, we evaluated whether the abundance 341 of 1,113 free soluble proteins in peripheral blood may be associated with AITD status 342
(27 AITD patients versus 130 healthy controls) and TPOAb levels (155 individuals) in 343 the TwinsUK cohort (Supplement Table 1 ) using aptamer-based multiplex protein 344 assay (SOMAscan) 55 . As there are partial correlations between proteins ( Fig. 4a) , we 345 identified 227 independent features using the Li and Ji's method 45 (Bonferroni multiple  346 testing correction, P-value<1.9x10 -4 ). Levels of three proteins were positively 347 associated with AITD status: TSH (P-value=8.67x10 -5 ; Beta=0.67; SE=0.16), 348
Caspase-2 (CASP-2; P-value=2.72x10 -7 ; Beta=1.10; SE=0.20) and Interleukin-1α (IL-349 1α; P-value=7.46x10 -5 ; Beta=0.41; SE=0.09). We also observed a higher level of TSH 350 on average in all patients with AITD or TPOAb-positivity compared with control 351 individuals (euthyroidism with TPOAb-negative). We observed a significant and 352 moderate correlation of TSH levels from two types of TSH measurement regardless 353 of manufacturer with ones from SOMAscan (Fig. 4b) . These indicate that the 354 SOMAscan assay is a relevant new technology to quantify the secretion levels of 355 soluble proteins, as previously described 56,57 . Although Caspase-2 and IL-1α levels 356
were associated with AITD status, Caspase-2 and IL-1α levels were not associated 357
with TPOAb or TSH levels as continuous variables (P-value>1.9x10 -4 ). However, 358 when participants were divided into 4 categories according to TSH and TPOAb levels 359 ( Fig.  4c) , reflecting different clinical categories (hyperthyroidism, 360 euthyroidism/TPOAb-negative, hypothyroidism and euthyroidism/TPOAb-positive), Caspase-2 showed significantly higher mean and variance in two groups: 362 hypothyroidism and euthyroidism/TPOAb-positive compared to euthyroidism/TPOAb-363 negative and hyperthyroidism ( Fig. 4d) . Participants in these two groups are likely to 364 have underlying Hashimoto's thyroiditis (HT). On the other hand, the variance of IL-1α 365 was significantly larger in groups with euthyroidism/TPOAb-positive and 366 hyperthyroidism than in the groups with euthyroidism/TPOAb-negative and 367 hypothyroidism ( Fig. 4e) , but no significant difference for their mean. This means that 368 on average, individuals from 4 categories have the same level of secretion of IL-1α, 369 but there are more inter-individual variabilities in euthyroidism/TPOAb-positive and 370 hyperthyroidism than euthyroidism/TPOAb-negative and hypothyroidism. 371
In summary, we replicated the association of the plasma TSH levels with AITD status, 372 and we found two novel associations of plasma protein levels of Caspase-2 and IL-1α 373 with AITD status, but their secretion (mean and variance) seems to also depend on 374 other factors associated with thyroid diseases such as the levels of TSH and TPOAb. 375 376 Afucosylated IgG is associated with serum levels of several circulating proteins
377
We next studied the correlation between the level of secreted TSH, Caspase-2 and 378 IL-1α proteins and IgG N-glycan trait levels in peripheral blood of 164 individuals but 379 found no significant associations (P-value>8.3x10 -4 , Bonferroni test considering only 380 3 independent proteins and 20 independent IgG N-glycan traits) (Supplement Table  381 6, Fig. 4f ). On the other hand, several AITD-IgG N-glycan traits appeared to be 382 associated with other circulating proteins (P-value<3.67x10 -5 , Bonferroni test in 383 considering only 227 independent proteins and 6 independent IgG N-glycan traits) 384 (Supplement Table 6 , Fig. 4f ). For example, three AITD-IgG N-glycan traits (IGP2, 385 IGP42, and IGP46) were positively associated with the circulating FCGR3B protein 386 (FcγRIIIb or CD16b), the receptor of polymorphonuclear neutrophils (PMN), whereas 387 three AITD-IgG N-glycan traits (IGP58, IGP59, and IGP60) were negatively associated 388 with FCGR3B protein. Also, IGP56 and IGP48 were negatively associated with β2-389 microglobulin, a protein involved in the presentation of intracellular antigens through 390 the MHC class I complex, and IGP48 was also positively associated with ERBB1 391 protein, also known as the epidermal growth factor receptor (EGFR), which serves as 392 a checkpoint for cell proliferation and differentiation.
Overall, 11 AITD-IgG N-glycan traits (IGP2, IGP8, IGP42, IGP46, IGP48, IGP56,  394 IGP58, IGP59, IGP60, IGP62, and IGP63) were associated with serum levels of 5 395 circulating proteins (AMHR2, BCMA, β2-microglobulin, ERBB1, and FCGR3B) in the 396 TwinsUK cohort, but no triplet (AITD, IgG N-glycan structures, and circulating proteins) 397 could be identified. More studies need to be performed to understand the relationships 398 between these two components of immune responses in AITD. 399 Recently, several GWASs on secreted proteins (protein quantification locus traits, 423 pQTL) have been performed 31 , which allowed us to determine whether the secretion 424 of proteins associated with AITD or with AITD-IgG N-glycan traits are driven by SNPs 425 also associated with AITD. We studied whether the SNPs previously associated with 426 plasma circulating protein abundance were also associated with at least one of thyroid 427 phenotypes published in the GWAS catalog including GD and TPOAb-positivity 30 and 428 with one of 17 AITD-IgG N-glycan structures. We found no SNPs associated with one 429 of 17 AITD-IgG N-glycan structures that are also pQTL. However, four genetic variants 430 associated with thyroid phenotypes (rs3761959, rs7528684, rs505922, and rs3184504) 431 are also associated in cis and trans with nine circulating protein abundances (BGAT, 432 CHSTB, DC-SIGN, Desmoglein-2, DYR, FCRL3, GP1BA, MBL, and VCAM-1) 433 (Supplement Table 7 ). None of these proteins were associated directly with AITD or 434
TPOAb levels in our study. However, we found that the Desmoglein-2 protein was associated with two AITD-IgG N-glycan traits, IGP8, and IGP63 4 (Supplement Fig. 3) . 436
This protein is highly expressed in epithelial cells including thyrocytes and 437 cardiomyocytes and plays a role in the cell-cell junction between epithelial, myocardial, 438 and certain other cell types. It was also proposed to be a novel regulator of apoptosis 59 . 439 Therefore, four genetic variants (rs3761959, rs7528684, rs505922, and rs3184504) 440 are associated with nine secreted protein abundances in blood and also associated 441 with several thyroid phenotypes. Further studies need to be performed to better 442 understand these links (e.g., causality, pleiotropy effects). potentially used as biomarkers. We previously identified a depletion of IgG core fucose 482 in the peripheral blood of people with AITD, and we suggested that this feature is 483 associated with TPOAb levels and may play a role in ADCC in patients with AITD 4 . 484 However, ADCC, as an immunological mechanism, depends on the formation of 485 antigen/antibody/Fc receptor complexes of substantial affinity or avidity. Thus, 486 immune effector cells and other molecules, such as ligands and secreted proteins are 487 also talented players in the activation of ADCC, and these were examined in this study. 488
489
We applied for the first-time an in silico multi-omic approach on individuals from the 490 TwinsUK cohort to better understand the cross-talk between immune features and 491 genetic variants in AITD. In AITD patient samples, we observed increased levels of 492 three circulating proteins (TSH, Caspase-2, and Interleukin-1α) and a decreased level 493 of IgG core fucosylation associated with a subpopulation of NK cells defined primarily 494 by the expression of CD335, CD134, and CD158b receptors. Our data confirmed the 495 previously reported association of plasma TSH level with AITD status and importantly revealed previously unknown biomarkers for AITD, which are highly associated with 497 immunological activation functions such as ADCC, apoptosis and pro-inflammatory 498 pathways. Several SNPs associated with AITD appear to alter the secretion of several 499 ligands of NK immunoreceptors in thyrocytes and plasma circulating proteins, showing 500 that genetic background may play potential roles in NK-ADCC in individuals with AITD. 501
502
The main limitation of our study is the lack of replication of our findings in other cohorts. 503
However, to our knowledge, no other cohorts have large datasets with the same 504 diversity of -omics data with AITD phenotype or TPOAb levels that would allow us to 505 fully or even partially replicate our findings. For example, NK cells are primarily 506 classified into only three subsets, CD56 -, CD56 dim, and CD56 bright , and not with other 507 immunoreceptors 64 . Using high-resolution deep immunophenotyping flow cytometry, 508 the categorization of immune cell traits performed in the TwinsUK cohort is composed 509 of a set of several immunoreceptors. Another limitation is the absence of in vitro 510 experimental evidence that could validate our findings. It is challenging to obtain 511 thyroid tissues from healthy individuals or patients with Hashimoto's thyroiditis, and to 512 our knowledge, no thyroid cell lines from patients with AITD are currently available. 513
We can, nevertheless, appreciate that different markers identified in our study 514 contribute to concluding the presence or activation of ADCC mechanisms in AITD. 515 516 Based on the TSH and TPOAb levels, Hashimoto's thyroiditis predominates in AITD 517 in our cohort. This finding was also observed in several other cohorts around the 518 world 65 . Although Hashimoto's thyroiditis is mostly characterized by the progressive 519 destruction of normal thyroid tissue 66 whereas Graves' disease is characterized by 520 stimulatory antibodies to the thyroid-stimulating hormone receptor (TSH-R), with 521 reduced apoptosis of thyrocytes 67 , previous studies have often not distinguished 522 between subgroups of AITD and that could make it more difficult to interpret further 523 findings. However, ADCC has been reported in AITD without restriction to subgroups 524 of patients with AITD using ADCC assays with extracted antibodies from the blood of 525 patients with the different subgroups of AITD. As expected, more patients with 526
Hashimoto's thyroiditis than with Graves' disease present ADCC activities 18, 19 .
Consequently, our cohort seems to represent the main mechanism in Hashimoto's 528 thyroiditis rather than in Graves' disease, namely the destruction of thyroid cells. 529 530 Interestingly, two secreted proteins (Caspase-2 and IL-1α), which play a role in 531 apoptosis and inflammatory response, were positively associated with AITD but were 532 not linearly associated with TPOAb and TSH levels. The Caspase-2 protein mediates 533 cellular apoptosis and plays a role in stress-induced cell death pathways and cell cycle 534 maintenance 68 . In addition to the positive association of Caspase-2 with AITD, we 535 observed an increase of its secretion in patients with hypothyroidism and 536 euthyroidism/TPOAb-positive. As TPOAb has been proposed to promote ADCC 537 against thyroid cells 4,10,18,19,69 , the Caspase-2 protein may represent a marker 538 signifying the destruction of thyroid cells by TPOAb. The IL-1α protein, on the other 539 hand, is a member of the interleukin 1 cytokine family and is produced mainly by 540 activated immune cells as well epithelial and endothelial cells in response to cell injury 541 and induces apoptosis. It is thus considered an apoptosis index of the target cell 70 . 542
Thyroid follicular cells produce IL-1α as well as IL-6 (no significant association 543 detected in this study), proportional to the degree of lymphoid infiltration in thyroid 544 disorders 62 . IL-1α seems to reduce the thyroid epithelial barrier without necessary 545 signs of general cytotoxicity 63 . In our study, the IL-1α protein was secreted more in 546 AITD than in healthy individuals and its variance was greater in euthyroidism/TPOAb-547 positive and hyperthyroidism. IL-1α levels thus could be a biomarker of dysregulation 548 in cell structures in the thyroid gland and suggest high variability in the levels of injured 549 thyroid cells in patients with AITD. Overall, one could speculate that Caspase-2 and 550 IL-1α could be potential biomarkers of the degree of tissue dysregulation, thyroid cell 551 death or apoptosis and lymphoid infiltration of the thyroid gland. 552 553 Glycome-wide association studies with immune cell traits in the general population 554 suggested that IgG core fucose levels are associated with a subpopulation of NK cells. 555
Here, in the bloodstream of the TwinsUK cohort we observed that IgG with core fucose 556 was positively associated with a subpopulation of NK cells with an activating NK 557 receptor (CD314) and a differentiation receptor (CD335) profile, whereas the same 558 IgG with core fucose was negatively associated with a subpopulation of NK cells with an inhibitory NK receptor (CD158b) and conversely between the same subpopulations 560 of NK cells featuring CD335, CD314, CD158b immunoreceptor expression with IgG 561 without core fucose. In the presence of IgG core fucose, three immunoreceptors, 562 CD335, CD314, CD158b, of NK cells appeared to play a role in the activation of 563 cytotoxicity of NK cells when they interact with their ligands on the target cells, which 564 are thyrocytes in AITD [39] [40] [41] [42] [43] [44] 71 , and this is expected to increase inflammation and 565 susceptibility to autoimmune disease 72 . 566
567
The role of IgG core fucosylation in ADCC could thus be enhanced via a cross-talk 568 with a subpopulation of NK cells. Previous studies showed that afucosylated 569 antibodies have a much higher affinity (100-fold) for FcγRIIIa (CD16a) and so, 570 enhance ADCC 73 . Moreover, a study using in vitro assay and human peripheral blood 571 cells showed that ADCC via FcγRIIIa requires NK cells, but not monocytes or 572 polymorphonuclear cells and that the activity levels of the antigen/antibody/effector 573 cell complexes correlated only with the NK cell numbers present in the PBMCs 24 . Our 574 associations between the level of IgG core fucose and of a subpopulation of NK cells 575 reinforce the notion that there is a complementarity between IgG core fucose levels 576 and NK cells, that could influence ADCC potency. 577 578 Moreover, our findings suggest that two opposing mechanisms combining NK 579 receptors with IgG core fucose levels are working together to achieve homeostasis in 580 NK cell activation, i.e. with IgG glycosylation as a way to fine-tune the balance between 581 activation and inhibition, depending on the NK cell repertoire, or conversely, the NK 582 cell repertoire may be a way to fine tune the presence of IgG. It is noteworthy that a 583 complex balance between activating receptors, inhibitory receptors and co-receptors 584 controls NK cell activation and cytotoxicity 74 . However, it was proposed that when 585 antibodies specific to an antigen, such as TPOAb on TPO, cross-link NK cells with 586 target cells, the activating stimulus from FcγRIIIa of NK cells overcomes inhibitory 587 signals 75 . This leads to the activation of NK cells, which release cytotoxic granules 588 containing perforin and granzymes, potentiating ADCC. Consequently, fine-tuning via 589 the IgG glycosylation proposed here can be complementary to the presence of multiple 590 receptors on NK cells in the activation of ADCC. This concept merits further 591 investigation. 592
593
The role of NK cells in AITD has been previously studied, but the measurement of NK 594 activity in the blood of individuals with AITD using in vitro assays produced variable 595 and potentially contradictory results, at first view 76, 77 . For example, one study showed 596 that an increase of NK cell activity is associated with a worsening of AITD, both in HT 597 and GD, and suggests that NK cells might contribute to the severity of disease in 598 autoimmune thyroid conditions 76 Although AITD are highly heritable (55-75%) 4 , no common additive genetic variance 608 between these different features studied here and AITD could be determined. We 609 previously estimated the heritability of AITD, IgG N-glycan traits, and immune cell traits 610 ( Supplement Table 8 ) 4, 27 . Although GWAS signals for a large panel secreted protein 611 levels were identified 31 , their heritability has not yet been estimated, and a previous 612 study estimated the heritability of only 342 secreted protein abundances 58 . To tackle 613 this gap, we estimated the proportion of genetic and environmental variance of 1,129 614 proteins studied in the present paper using the Structural Equation Modeling and twin 615 structures present in the TwinsUK cohort (Supplement Table 9 ). We found a small 616 proportion of proteins having additive genetic variances in their heritability, which is in 617 concordance with previous findings 58 . As the best model of heritability in AITD is only 618 with dominant genetic variance, the shared genetic variance between AITD and 619 proteins could not be estimated with accuracy as well as with IgG N-glycan traits and 620 immune cell traits. 621
On the other hand, in our study, we identified several genetic variants previously 623 associated with thyroid phenotypes to be also associated with the secretion of proteins 624 and ligands of two immunoreceptors. Specifically, we found that two genetic variants, inhibit, but trigger the production of cytokines and cytotoxicity by these NK cells, and 634 thus trigger ADCC. Thus, drawing from the knowledge generated in a large number of 635 previous reports and from our present findings, our study highlights different immune 636 features (glycan structures on antibodies, a subpopulation of NK cells, the secretion 637 of Caspase-2 and IL-1α) as potential biomarkers of AITD status detectable in the 638 bloodstream in addition to TSH and TPOAb levels. Moreover, if one speculates that 639 active antibodies with low core-fucose are thyroid autoantibodies (e.g., TPOAb) and 640 target cells are thyroid cells, we could propose that these biomarkers crosstalk in an 641 antibody-dependent NK cell-mediated cytotoxicity-associated fashion in individuals 642 with AITD 10,79 . In support of this, we found that two genetic variants, rs1521 and 643 rs3094228, associated with AITD which could participate in this crosstalk in altering 644 the expression of ligands (MIC-A, MIC-B, and HLA-C) of NK immunoreceptors (CD314 645 and CD158b) in thyrocytes. We thus propose a model of positive autoreactive 646 antibody-dependent NK cell-mediated cytotoxicity in the thyroid gland of AITD patients 647 illustrated in Fig. 5 15,18,19 ,80,81 . 648
649
We also speculate that targeting TPOAb, perhaps only by their glycosylation 82 , or a 650 subpopulation of NK cells in patients with HT may lead to a deceleration in the 651 destruction of the thyroid gland and could lead to potential complementary targets for 652 drugs in the treatment of hypothyroidism and HT. On the other hand, the combination 653 of afucosylated TPOAb with the activation of a specific subpopulation of NK cells could trigger the lysis of thyroid cells and could also be a new potential treatment in 655 disseminated radioactive iodine-resistant differentiated thyroid cancer. A previous in 656 vitro study 69 tested the hypothesis that TPOAb from patients with GD could be used 657 as thyroid cancer immunotherapy and showed potential to destroy thyroid cells, more 658 precisely thyroid cancer cells that express cell surface TPO proteins, by ADCC or CDC 659 involving monocytes or NK cells as effector cells. They observed that the 660 deglycosylation of TPOAb reduced the binding to FcγRs and thus inhibited the The samples for immune cell traits, glycosylation, proteomics, and GWAS for immune 673 cell traits consisted of twins from the UK Adult Twin Registry (TwinsUK cohort). The 674
TwinsUK cohort is comprised of approximately 12,000 monozygotic and dizygotic 675 twins unselected for any particular disease or trait. The cohort is from Northern 676 European/UK ancestry and has been shown to be representative of singleton 677 populations and the UK population in general 90,91 . The project was approved by the 678 local Ethics Committee, and informed consent was obtained from all participants. The 679
TwinsUK cohort for each omics is described in the Supplementary Table 1 
Detection of TSH and TPOAb and Definition of AITD

684
The study was performed using a clinical AITD definition and TPOAb as a threshold 685 trait as we do not have clinical diagnostic data related to AITD confirmed by a clinician. 686
Individuals were considered to have AITD if they had a positive TPOAb titer (3 times 687 more than the threshold set by the manufacturer [18 IU/mL for Abbott assay and 100 688 IU/mL for Roche assay]) or had a TSH level more than 10 mIU/L. On the other hand, 689
we considered individuals as controls if they had a TSH level in the normal range and 690 a negative TPOAb titer, with no previous clinical diagnosis of thyroid disease and not 691 treated with thyroid medications or steroids. Individuals with a history of thyroid cancer 692 or thyroid surgery were excluded. analysis of 2AB-labelled glycans. The protocol, as well as the data pre-processing and 708 normalization of data in the TwinsUK cohort, was previously described 4 . Briefly, using 709 UPLC analysis of 2AB-labelled glycans, the chromatograms were all separated in the 710 same manner into 24 peaks, and the amount of glycans in each peak was expressed 711 as a percentage of the total integrated area. One glycan was excluded before any 712 transformation and standardization of data because of its co-elution with a 713 contaminant that significantly affected its values in some samples whereas two glycan 714 peaks (GP) GP20 and GP21 (Zagreb code) were combined into a single trait called 715 GP2021 (Zagreb code) because of difficulty in distinguishing between these peaks in 716 some samples. A global normalization and natural logarithm transformation were 717 applied to 22 directly measured glycan structures. As many of these structures share 718 the same structural features (galactose, sialic acid, core-fucose, bisecting N-719 acetylglucosamine (GlcNAc)), 55 additional derived traits were calculated that average 720 these features across multiple glycans from the 22 normalized and non-transformed 721 directly measured glycans. Technical confounders (batch and run-day effects) were 722 addressed using R package ComBat. The 22 directly measured glycans and 55 723 derived glycan traits were centered and scaled to have a mean of 0 and standard 724 deviation (SD) of 1. Samples being more than 6 SD from the mean were considered 725 as outliers and excluded from the analysis. 726
Detection of immune cell traits
727
Plasma samples for assessment of 78,000 immune traits have collected between 2010 728 and 2012 in 669 female participants from the UK Adults Twin Register, TwinsUK (497 729 for a discovery cohort and 172 for a replication cohort) using high-resolution deep 730 immunophenotyping flow cytometry analysis with a protocol described previously 28 . 731 78,000 cell-types captured by 7 distinct 14-color immunophenotyping panels were Where Yi represents the quantification of immune cell traits for individual i and Gij is 784 glycan structure of type j among 75 N-glycans for the same individual i. If biological 785 covariates (age, sex) have not been adjusted before association analysis, they have 786 been added in the model. A random intercept was added only in the discovery cohort 787 in order to model the family-relatedness. 788
To examine whether an immune cell trait was significantly associated with TPOAb 789 level and AITD status, we compared the fitted model in equation (2) with a model that 790 did not include the immune cell traits in equation (1) where Gij become the immune 791 cell trait of type j among 23,485 in discovery cohort for the same individual i. For the discovery and replication cohorts in TwinsUK, we added a random intercept in order 793 to model the family-relatedness. 794
To examine whether one of the 1,113 protein was significantly associated with TPOAb 795 level and AITD status, we compared the fitted model in equation (2) with a model that 796 did not include the protein in equation (1): where Gij become the protein of type j 797 among 1,129 in discovery cohort for the same individual i. We added a random 798
intercept in order to model the family-relatedness. 799
To examine whether one of 1,113 proteins was significantly associated with one of 17 800 significant glycans, we compared the fitted model in equation (2) with a model that did 801 not include the protein in equation (1): where Gij become the protein of type j among 802 1,129 in discovery cohort for the same individual i. We added a random intercept in 803 order to model the family-relatedness. 804
Genome-wide Association Analysis on IgG N-glycan traits, immune cell traits, proteins, gene 805 expressions in several tissues, and thyroid phenotypes 806
To define the list of SNPs associated with glycosylation profiles regardless of specific 807 phenotypes in the TwinsUK cohort, we ran analyses using GenABEL software 808 package 98 , which is designed for GWAS analysis of family-based data by incorporating 809 pairwise kinship matrix calculated using genotyping data in the polygenic model to 810 correct relatedness and hidden population stratification. We selected SNPs for each 811 IgG N-glycan traits that have a P-value under GWAS P-value threshold (P-value < 812 5x10 -8 ). Moreover, we added the list of SNPs previously defined 29, 99 . 813
To define the list of SNPs associated with immune cell traits regardless to any specific 814 phenotypes in the TwinsUK cohort, we ran extracted SNPs for each immune cell traits 815 that have a P-value under GWAS P-value threshold (P-value < 5x10 -8 ) from previous 816 published GWASs on these immune cell traits 27, 28 . 817
To define the list of SNPs associated with protein abundance found in this study, we 818 extracted the significant SNPs reported in INTERVAL project 31 . 819
To define the list of SNPs associated with gene expression (eQTL), we extracted the 820 eQTLs reported significant by GTEx and previous papers present in HaploReg 821 V4.1 31,32 .
To define the list of SNPs associated with AITD and thyroid functions, we selected to 823 SNPs listed in the NHGRI GWAS catalog 30 with words "thyroid" or "Graves" or 824 Heatmaps were created in using R package ComplexHeatmap, and we visualized only 853 beta values having significant associations from linear mixed models ( Fig. 2a and 4f ).
Correlation between 51 immune cell traits and between 17 AITD-IgG N-glycans ( Fig  855   2b and c) were created with R package corrplot. Boxplots and scatter plot were created 856 in using R package ggplot2 (Fig 4b-e ). 
